1. Home
  2. CELU vs LITB Comparison

CELU vs LITB Comparison

Compare CELU & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • LITB
  • Stock Information
  • Founded
  • CELU 2016
  • LITB 2007
  • Country
  • CELU United States
  • LITB Singapore
  • Employees
  • CELU N/A
  • LITB N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • LITB Catalog/Specialty Distribution
  • Sector
  • CELU Health Care
  • LITB Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • LITB Nasdaq
  • Market Cap
  • CELU 40.9M
  • LITB 37.9M
  • IPO Year
  • CELU N/A
  • LITB N/A
  • Fundamental
  • Price
  • CELU $2.46
  • LITB $2.01
  • Analyst Decision
  • CELU
  • LITB
  • Analyst Count
  • CELU 0
  • LITB 0
  • Target Price
  • CELU N/A
  • LITB N/A
  • AVG Volume (30 Days)
  • CELU 3.1M
  • LITB 11.2K
  • Earning Date
  • CELU 11-07-2024
  • LITB 11-29-2024
  • Dividend Yield
  • CELU N/A
  • LITB N/A
  • EPS Growth
  • CELU N/A
  • LITB N/A
  • EPS
  • CELU N/A
  • LITB N/A
  • Revenue
  • CELU $42,690,000.00
  • LITB $430,411,000.00
  • Revenue This Year
  • CELU N/A
  • LITB N/A
  • Revenue Next Year
  • CELU $233.89
  • LITB N/A
  • P/E Ratio
  • CELU N/A
  • LITB N/A
  • Revenue Growth
  • CELU 182.02
  • LITB N/A
  • 52 Week Low
  • CELU $1.30
  • LITB $1.85
  • 52 Week High
  • CELU $7.97
  • LITB $7.98
  • Technical
  • Relative Strength Index (RSI)
  • CELU 49.49
  • LITB 37.86
  • Support Level
  • CELU $3.26
  • LITB $1.85
  • Resistance Level
  • CELU $4.34
  • LITB $2.12
  • Average True Range (ATR)
  • CELU 0.84
  • LITB 0.19
  • MACD
  • CELU 0.11
  • LITB 0.01
  • Stochastic Oscillator
  • CELU 29.59
  • LITB 35.56

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company is engaged in product sales which consisted of online retailing of consumer products. It also provides services which consisted of the provision of logistic services to e-commerce retailers and small businesses. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

Share on Social Networks: